Влияние эзетимиба и симвастина на агрегацию тромбоцитов и систему протеина с при лечении больных ишемической болезнью сердца с гиперхолестеринемией

Ващенко Татьяна Николаевна, Kozobova Ai, Филиппов Александр Евгеньевич et al. · CyberLeninK (CyberLeninka) · 2012

Therapy with ezetimib (10 mg daily for 2 weeks) caused a 24% reduction of plasma LDL cholesterol level (p<0.05) and maximum ADP and collagen-induced platelet aggregation from 76.2+-1.54 to 65.3+-3.38% and from 71.5+-3.98 to 53.6+5.24% (p<0.05) respectively. Combination of ezetimibe and simvaststin did not produce an additional decrease in platelet aggregation.

Cited by 0 works.

Authors